---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011084"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T05:19:02.496378+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vivos Q1 2025 product rev +8% YoY, net loss $3.9M; acquires Sleep Center of Nevada for up to $9M

## Summary
- Revenue $3.0M (-12% YoY) as pivot away from VIP service revenue; product revenue up 8% to $1.8M from appliance arch sales.
- Net loss $3.9M (+3% YoY); operating expenses $5.4M (-5% YoY) reflecting cost-cutting.
- Cash $2.3M, equity $4.4M at March 31, 2025.
- Entered definitive agreement on April 15, 2025 to acquire The Sleep Center of Nevada for up to $9M cash/stock; expected close within two months.
- Sold 3,736 oral appliance arches (vs 1,996 in Q1 2024) driving product revenue increase.

## SEC filing metadata
- accession: 0001641172-25-011084
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000164117225011084/0001641172-25-011084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000164117225011084/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011084
- JSON: https://secwatch.observer/filing/0001641172-25-011084.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.